These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 35939511)

  • 61. Competitive ELISA for the Detection and Quantification of Mycobacterium ulcerans Mycolactone.
    Warryn L
    Methods Mol Biol; 2022; 2387():151-161. PubMed ID: 34643910
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The potent effect of mycolactone on lipid membranes.
    Nitenberg M; Bénarouche A; Maniti O; Marion E; Marsollier L; Géan J; Dufourc EJ; Cavalier JF; Canaan S; Girard-Egrot AP
    PLoS Pathog; 2018 Jan; 14(1):e1006814. PubMed ID: 29320578
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Analysis of Mycobacterium species for the presence of a macrolide toxin, mycolactone.
    Daniel AK; Lee RE; Portaels F; Small PL
    Infect Immun; 2004 Jan; 72(1):123-32. PubMed ID: 14688089
    [TBL] [Abstract][Full Text] [Related]  

  • 64. FVB/N Mice Spontaneously Heal Ulcerative Lesions Induced by Mycobacterium ulcerans and Switch M. ulcerans into a Low Mycolactone Producer.
    Marion E; Jarry U; Cano C; Savary C; Beauvillain C; Robbe-Saule M; Preisser L; Altare F; Delneste Y; Jeannin P; Marsollier L
    J Immunol; 2016 Mar; 196(6):2690-8. PubMed ID: 26873988
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pathogenetic mechanisms of the intracellular parasite Mycobacterium ulcerans leading to Buruli ulcer.
    Silva MT; Portaels F; Pedrosa J
    Lancet Infect Dis; 2009 Nov; 9(11):699-710. PubMed ID: 19850228
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Naturally occurring a loss of a giant plasmid from Mycobacterium ulcerans subsp. shinshuense makes it non-pathogenic.
    Nakanaga K; Ogura Y; Toyoda A; Yoshida M; Fukano H; Fujiwara N; Miyamoto Y; Nakata N; Kazumi Y; Maeda S; Ooka T; Goto M; Tanigawa K; Mitarai S; Suzuki K; Ishii N; Ato M; Hayashi T; Hoshino Y
    Sci Rep; 2018 May; 8(1):8218. PubMed ID: 29844323
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Conditions for Handling and Optimal Storage of Mycolactone.
    Kubicek-Sutherland JZ; Swanson BI; Mukundan H
    Methods Mol Biol; 2022; 2387():109-116. PubMed ID: 34643907
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana].
    Sambourg E; Dufour J; Edouard S; Morris A; Mosnier E; Reynaud Y; Sainte-Marie D; Nacher M; Guégan JF; Couppié P
    Ann Dermatol Venereol; 2014; 141(6-7):413-8. PubMed ID: 24951139
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Microbiological, histological, immunological, and toxin response to antibiotic treatment in the mouse model of Mycobacterium ulcerans disease.
    Sarfo FS; Converse PJ; Almeida DV; Zhang J; Robinson C; Wansbrough-Jones M; Grosset JH
    PLoS Negl Trop Dis; 2013; 7(3):e2101. PubMed ID: 23516649
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Uptake and cellular actions of mycolactone, a virulence determinant for Mycobacterium ulcerans.
    Snyder DS; Small PL
    Microb Pathog; 2003 Feb; 34(2):91-101. PubMed ID: 12623277
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin.
    Mve-Obiang A; Lee RE; Umstot ES; Trott KA; Grammer TC; Parker JM; Ranger BS; Grainger R; Mahrous EA; Small PL
    Infect Immun; 2005 Jun; 73(6):3307-12. PubMed ID: 15908356
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Limited repair and structural damages displayed by skeletal muscles loaded with mycolactone.
    Houngbédji GM; Côté CH; Small PL; Frenette J
    Microbes Infect; 2009 Feb; 11(2):238-44. PubMed ID: 19114122
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cellular immunity confers transient protection in experimental Buruli ulcer following BCG or mycolactone-negative Mycobacterium ulcerans vaccination.
    Fraga AG; Martins TG; Torrado E; Huygen K; Portaels F; Silva MT; Castro AG; Pedrosa J
    PLoS One; 2012; 7(3):e33406. PubMed ID: 22413022
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Impact of mycolactone produced by Mycobacterium ulcerans on life-history traits of Aedes aegypti (L.) and resulting habitat selection for oviposition.
    Mashlawi AM; Jordan HR; Crippen LT; Tomberlin JK
    Trop Biomed; 2020 Dec; 37(4):973-985. PubMed ID: 33612750
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Molecular Characterization of Mycolactone Producing Mycobacteria from Aquatic Environments in Buruli Ulcer Non-Endemic Areas in Côte d'Ivoire.
    Tano MB; Dassi C; Mosi L; Koussémon M; Bonfoh B
    Int J Environ Res Public Health; 2017 Feb; 14(2):. PubMed ID: 28208653
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Local Cellular Immune Responses and Pathogenesis of Buruli Ulcer Lesions in the Experimental Mycobacterium Ulcerans Pig Infection Model.
    Bolz M; Ruggli N; Borel N; Pluschke G; Ruf MT
    PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004678. PubMed ID: 27128097
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Structure of the Inhibited State of the Sec Translocon.
    Gérard SF; Hall BS; Zaki AM; Corfield KA; Mayerhofer PU; Costa C; Whelligan DK; Biggin PC; Simmonds RE; Higgins MK
    Mol Cell; 2020 Aug; 79(3):406-415.e7. PubMed ID: 32692975
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An Antigen Capture Assay for the Detection of Mycolactone, the Polyketide Toxin of
    Warryn L; Dangy JP; Gersbach P; Gehringer M; Altmann KH; Pluschke G
    J Immunol; 2021 Jun; 206(11):2753-2762. PubMed ID: 34031146
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Mycobacterium ulcerans cytotoxicity in an adipose cell model.
    Dobos KM; Small PL; Deslauriers M; Quinn FD; King CH
    Infect Immun; 2001 Nov; 69(11):7182-6. PubMed ID: 11598099
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Proteomic analysis of the action of the Mycobacterium ulcerans toxin mycolactone: targeting host cells cytoskeleton and collagen.
    Gama JB; Ohlmeier S; Martins TG; Fraga AG; Sampaio-Marques B; Carvalho MA; Proença F; Silva MT; Pedrosa J; Ludovico P
    PLoS Negl Trop Dis; 2014 Aug; 8(8):e3066. PubMed ID: 25101965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.